Moxifloxacin and Sotalol Interaction

Understanding the Moxifloxacin and Sotalol Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Moxifloxacin belongs to the Fluoroquinolone Antibiotic class and Sotalol belongs to the Class III Antiarrhythmic / Beta-Blocker class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Both drugs can change the electrical timing of your heartbeat, which might increase the risk of a dangerous heart rhythm. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Moxifloxacin has 10 total documented interactions on file in this dataset, and Sotalol has 13. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may need to monitor your heart's electrical activity with an EKG if these medications are used at the same time. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Moxifloxacin or Sotalol based on a web page, speak with your prescriber or pharmacist before making any change.